Home > Investor

Investor

Share Trends
Stock Performance
Warsaw Stock Exchange
Bulgarian Stock Exchange
Corporate News
28 October 2021
The Executive Director of Sopharma met with Vice President of Vietnam Mrs. Vo Thi Anh Xuan
Financial News
1 July 2024
Notification of sale of treasury shares as of 1 July 2024
28 June 2024
Notification on the terms and conditions for distribution of the dividend
27 June 2024
Notification of sale of treasury shares as of 27 June 2024
Financial Highlights 31 March, 2022
397 570
BGN '000 Revenue
34 368
BGN '000 EBITDA
21 827
BGN '000 Revenue from operating profit
22 560
BGN '000 Net profit for the year
0.17
BGN Earnings per share

Next events
22 July 2024
Financial revenues for January-June 2024
30 July 2024
Individual financial statements for Q2 of 2024

Equity story

85+ year track record in the pharma industry

  • Leadership
  • Growth
  • Portfolio
  • Profitability
  • Business Model
  • M&A